Vanessa Vivian Calabria, DO | |
818 Riverside Ave, Adrian, MI 49221-1446 | |
(517) 265-0900 | |
Not Available |
Full Name | Vanessa Vivian Calabria |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 818 Riverside Ave, Adrian, Michigan |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1972916559 | NPI | - | NPPES |
5315066355 | Other | MI | CONTROLLED SUBSTANCE LICENSE |
5101021264 | Other | MI | PHYSICIAN LICENSE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 5101021264 (Michigan) | Primary |
207P00000X | Emergency Medicine | 02007549A (Indiana) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Vanessa Vivian Calabria, DO 818 Riverside Ave, Adrian, MI 49221-1446 Ph: (517) 265-0900 | Vanessa Vivian Calabria, DO 818 Riverside Ave, Adrian, MI 49221-1446 Ph: (517) 265-0900 |
News Archive
Scientists in Scotland have come up with a revolutionary way of treating common skin cancers.
Researchers have designed a safer, faster and cheaper cell-based regenerative therapy approach for the treatment of one of the most common human dental diseases, namely periodontitis.
Today AIDS Healthcare Foundation (AHF) announced that California State Controller John Chiang has sent letters to the CEOs of Abbott, Boehringer Ingelheim (BI), Bristol-Myers Squibb (BMS) and Genentech, asking the companies to reduce the price of their HIV/AIDS medications for California and its AIDS Drug Assistance Program (ADAP).
High groundwater concentration of lithium, a naturally occurring trace element, wasn't associated with any benefit in diagnoses of bipolar disorder or dementia when accounting for local health care resources and demographics, two factors that can cause mental health diagnosis rates to vary.
After more than a decade of development at the National Institutes of Health, a vaccine to prevent infection by the mosquito-borne dengue virus has begun human clinical testing. The vaccine was developed by scientists at the National Institute of Allergy and Infectious Diseases (NIAID) and is undergoing clinical study at the Johns Hopkins Bloomberg School of Public Health in Baltimore.
› Verified 2 days ago
Rosalie Turek, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 818 Riverside Ave, Adrian, MI 49221 Phone: 517-265-0900 | |
Howard Merritt, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 818 Riverside Ave, Adrian, MI 49221 Phone: 517-265-0900 |